These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5589124)

  • 1. [Anomalies of platelet behavior at the time of myocardial infarct].
    Bouvier CA; Rosner P; Berthoud S; Ritschard J; Scherrer JR; Hausser E
    Cardiologia (Basel); 1967; 50(4):232-8. PubMed ID: 5589124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet anti-aggregating therapy with dipyridamole in the prevention of early post-infarct angina].
    Pavia M; Idone P; Ravera A; Rey L; Trucco G; Aquaro G
    Minerva Cardioangiol; 1981 Dec; 29(12):729-33. PubMed ID: 7335171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anomalies of platelet behavior associated with myocardial infarct].
    Bouvier CA; Ritschard J
    Brux Med; 1970 Sep; 50(9):623-34. PubMed ID: 5510363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet function disorders and ischemic cerebral accidents. Therapeutic prospects].
    Géraud J; Rascol A; Bierme R; Boneu B; Guiraud B; Fernet P; Géraud G; David J
    Rev Neurol (Paris); 1972 Jan; 126(1):31-40. PubMed ID: 4635139
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dipyridamole therapy in acute myocardial infarct].
    Avdiushko BR
    Vrach Delo; 1977 Jan; (1):38-43. PubMed ID: 841989
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiaggregant effect of slow-release dipyridamole in acute myocardial infarct].
    Scabbia E; Bellocci F; Montenero AS; Albanese S; Coppola E; Cudillo L
    Minerva Cardioangiol; 1988; 36(7-8):347-50. PubMed ID: 2974931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants].
    Melloni GF; Lureti GF; Minoja GM; Melloni CF; Scarlatti GF; Facchetti M; Fassini G
    Boll Soc Ital Cardiol; 1977; 22(7):1017-26. PubMed ID: 87208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L; Balzano I
    Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract]   [Full Text] [Related]  

  • 10. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 12. Dipyridamole: a controlled trial of its effect in acute myocardial infarction.
    Gent AE; Brook CG; Foley TH; Miller TN
    Br Med J; 1968 Nov; 4(5627):366-8. PubMed ID: 4879059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emergency treatment of acute myocardial infarct by means of slow intravenous infusion of a derivative of pyrimido-(5,4-d)-pyrimidine (preparation RA8)].
    Capelli F; Lotto A; Lomanto B
    Minerva Cardioangiol; 1966 Jun; 14(6):367-73. PubMed ID: 5917540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of intravenous administration of curantil on hemodynamics in patients with acute myocardial infarct].
    Davydova NT; Ianovskiĭ AD
    Vrach Delo; 1976 Feb; (2):4-8. PubMed ID: 1266150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-platelet-aggregating action of dipyridamole administered by slow intravenous infusion].
    Francini D; Abbate R
    Clin Ter; 1980 Mar; 92(5):477-89. PubMed ID: 7449325
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of dipyridamol in the acute period of myocardial infarction].
    Avdiushko BR
    Vrach Delo; 1977 Jan; (1):38-43. PubMed ID: 847943
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
    Teik KO; Poh FW; Fun CS; Mong BC
    Med J Malaya; 1966 Mar; 20(3):186-204. PubMed ID: 4223070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of administration of hydrocortisone and dipyridamole (persantin) on plasma levels of prostaglandin E1 and F2 alpha in patients with myocardial infarction].
    Miturzyńska-Stryjecka H
    Wiad Lek; 1987 Nov; 40(21):1441-6. PubMed ID: 3482754
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of vasodilation through dipyridamole on the extent of acute experimental infarct].
    Bleifeld W; Wende W; Meyer J; Bussmann WD
    Z Kardiol; 1974 Feb; 63(2):115-28. PubMed ID: 4409852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.